jueves, 14 de mayo de 2026

NOVICHOK Fourth-Generation Organophosphorus Nerve Agents

NOVICHOK

Fourth-Generation Organophosphorus Nerve Agents

Molecular Neurotoxicology, Cholinergic Pathophysiology, CBRN Tactical Medicine, Chemical Intelligence and Modern Warfare

By DrRamonReyesMD ⚕️ | Updated 2026

INTRODUCTION

The agents known as Novichok represent one of the most sophisticated, clandestine and controversial developments in modern chemical warfare.

From a scientific standpoint, they are not merely “poisons”. They are:

ultra-potent organophosphorus acetylcholinesterase inhibitors

designed for:

rapid incapacitation,
extreme lethality,
operational persistence,
analytical detection difficulty,
historical evasion of international chemical-control lists.

The Novichok family reshaped the modern understanding of:

chemical warfare,
chemical terrorism,
CBRN tactical medicine,
toxicological intelligence,
civil protection.

ETYMOLOGY AND NOMENCLATURE

“Novichok” comes from the Russian Новичок, meaning:

“newcomer”,
“new arrival”,
“novice”.

However, in modern Western scientific and operational terminology, many of these compounds are referred to as:

A-series nerve agents

including:

A-230,
A-232,
A-234,
A-242,
A-262.

The exact number of compounds developed remains partially classified or uncertain.

ADVANCED ORGANOPHOSPHORUS CHEMISTRY

Novichok agents belong to the broader group of:

organophosphorus neurotoxic compounds

functionally related to:

sarin,
soman,
tabun,
VX.

However, they show important structural and operational differences, including:

modified phosphoramidates,
complex nitrogen-containing groups,
high enzymatic affinity,
potential binary formulations,
increased analytical complexity.

Their precise structural details, toxicokinetics and comparative potency vary between individual agents.

LIPOPHILICITY AND TISSUE PENETRATION

Many Novichok-related agents are believed to possess:

significant lipophilicity,
dermal penetration capacity,
environmental persistence,
surface contamination potential,
prolonged secondary exposure risk.

This has major tactical implications.

Exposure may occur through:

inhalation,
skin contact,
ocular contact,
mucosal absorption,
contaminated objects,
secondary contact with clothing or surfaces.

PHARMACOKINETICS

Absorption

Potential routes include:

inhalational,
dermal,
oral,
ocular,
mucosal.

Distribution

After absorption, these agents may rapidly affect:

peripheral neuromuscular junctions,
autonomic ganglia,
parasympathetic effector organs,
central nervous system structures.

Metabolism and forensic signatures

Available public data remain incomplete, but modern toxicology has demonstrated that exposure may be investigated through:

cholinesterase inhibition,
protein adducts,
phosphylated biomolecules,
mass spectrometry-based biomarkers.

ACETYLCHOLINE: THE CENTRAL BIOCHEMICAL TARGET

Acetylcholine is a fundamental neurotransmitter involved in:

skeletal muscle contraction,
parasympathetic autonomic function,
glandular secretion,
bronchial tone,
cardiac modulation,
cognition and memory.

The enzyme:

acetylcholinesterase (AChE)

normally terminates acetylcholine signalling by rapidly hydrolysing acetylcholine in the synaptic cleft.

When Novichok agents inhibit acetylcholinesterase:

acetylcholine accumulates uncontrollably

at:

muscarinic receptors,
nicotinic receptors,
central cholinergic synapses.

The result is a potentially lethal:

cholinergic crisis.

MUSCARINIC EFFECTS

Muscarinic overstimulation affects:

airways,
glands,
gastrointestinal tract,
heart,
pupils,
smooth muscle.

Typical manifestations include:

pinpoint miosis,
blurred vision,
lacrimation,
rhinorrhoea,
hypersalivation,
bronchorrhoea,
bronchospasm,
bradycardia,
vomiting,
diarrhoea,
sweating,
urinary incontinence.

The most immediately lethal muscarinic effects are:

bronchorrhoea + bronchospasm + hypoxaemia.

NICOTINIC EFFECTS

Nicotinic receptor involvement affects:

neuromuscular junctions,
autonomic ganglia.

Clinical findings include:

fasciculations,
muscle cramps,
weakness,
paralysis,
diaphragmatic failure,
respiratory muscle collapse.

This is why atropine alone is not enough: atropine treats muscarinic toxicity but does not directly reverse neuromuscular paralysis.

CENTRAL NERVOUS SYSTEM TOXICITY

Central nervous system involvement may produce:

anxiety,
confusion,
seizures,
coma,
respiratory depression,
central apnoea,
neuronal injury,
long-term neurocognitive sequelae.

Severe poisoning can induce:

refractory status epilepticus

with secondary:

excitotoxicity,
cerebral hypoxia,
neuroinflammation,
mitochondrial dysfunction,
oxidative stress.

GLUTAMATERGIC EXCITOTOXICITY

Severe cholinergic crisis may trigger excessive glutamate release and overstimulation of NMDA receptors.

This causes:

intracellular calcium overload,
mitochondrial injury,
free radical generation,
neuronal apoptosis or necrosis.

This mechanism may contribute to:

memory impairment,
executive dysfunction,
psychiatric sequelae,
chronic fatigue,
post-toxic encephalopathy.

MITOCHONDRIAL AND OXIDATIVE INJURY

Modern neurotoxicology suggests that severe organophosphorus poisoning may also involve:

oxidative stress,
mitochondrial dysfunction,
impaired ATP production,
neuronal energy failure,
apoptotic signalling,
inflammatory cascades.

This helps explain why survival from nerve-agent exposure does not always mean full neurological recovery.

RESPIRATORY FAILURE: THE TERMINAL PATHWAY

Death usually results from combined respiratory failure.

The mechanisms include:

1. Bronchorrhoea

The airways fill with secretions.

2. Bronchospasm

Severe narrowing of the bronchial tree worsens ventilation.

3. Diaphragmatic paralysis

Neuromuscular transmission fails.

4. Central respiratory depression

The brainstem loses effective respiratory control.

5. Hypoxia and acidosis

Progressive oxygen failure leads to:

lactic acidosis,
arrhythmia,
cardiac arrest,
multiorgan failure.

ENZYMATIC “AGING”

One of the most important biochemical concepts in nerve-agent toxicology is:

aging

After a nerve agent binds to acetylcholinesterase, the enzyme-agent complex may undergo chemical stabilization. Once aging occurs, oximes may no longer effectively reactivate acetylcholinesterase.

This has enormous clinical relevance:

treatment is time-critical.

Oximes such as pralidoxime, obidoxime or HI-6 are most useful before aging becomes established.

TOXICITY: WHAT IS KNOWN AND WHAT REMAINS UNCERTAIN

Many public claims describe Novichok agents as:

“five times more toxic than VX”,
“ten times more toxic than VX”,
“the deadliest nerve agents ever made”.

These statements are often oversimplified.

The scientific truth is more cautious:

exact human toxic doses are not publicly established for all agents,
much data remain classified or extrapolated,
toxicity depends on the specific compound,
route of exposure matters greatly,
formulation, purity and delivery method modify lethality.

What can be stated with confidence:

Novichok agents are highly potent, dangerous organophosphorus nerve agents capable of lethal poisoning at very small exposure levels.

BINARY FORMULATIONS

A major strategic feature attributed to some Novichok agents is the possibility of binary formulation.

This means that two less immediately toxic precursors may be stored separately and mixed shortly before use.

Operational advantages include:

easier storage,
lower risk to handlers,
more difficult intelligence detection,
more complex forensic reconstruction,
possible historical evasion of treaty schedules.

COMPARISON WITH CLASSICAL NERVE AGENTS

Sarin

highly volatile,
rapid inhalational hazard,
less persistent than VX.

VX

very persistent,
highly dermally toxic,
oily liquid,
major surface contamination hazard.

Novichok

variable physicochemical profile,
high potency,
potentially persistent,
analytically complex,
associated with covert state-level chemical operations.

CLINICAL PRESENTATION

Early phase

miosis,
blurred vision,
headache,
rhinorrhoea,
sweating,
anxiety,
chest tightness.

Intermediate phase

vomiting,
diarrhoea,
bronchospasm,
bronchorrhoea,
fasciculations,
weakness,
dyspnoea.

Severe phase

seizures,
coma,
paralysis,
apnoea,
hypoxic shock,
cardiac arrest.

DIAGNOSIS

Initial diagnosis is usually:

clinical-operational

especially in:

CBRN incidents,
military environments,
terrorism scenarios,
HAZMAT operations,
unexplained mass-casualty cholinergic syndromes.

Key clues include:

sudden miosis in multiple victims,
secretions,
respiratory distress,
fasciculations,
seizures,
contaminated scene,
responder symptoms.

BIOMARKERS AND LABORATORY CONFIRMATION

Laboratory confirmation may involve:

erythrocyte acetylcholinesterase activity,
plasma butyrylcholinesterase activity,
LC-MS/MS,
high-resolution mass spectrometry,
protein adduct detection,
phosphylated peptide identification.

Erythrocyte acetylcholinesterase is often more clinically relevant than plasma cholinesterase because it better reflects synaptic acetylcholinesterase inhibition.

MEDICAL MANAGEMENT

1. Scene safety

No treatment plan works if rescuers become casualties.

Priorities:

identify hot zone,
use appropriate PPE,
prevent secondary contamination,
establish decontamination corridors.

2. Decontamination

Essential actions include:

removal of clothing,
containment of contaminated material,
copious water irrigation when appropriate,
avoidance of uncontrolled spread,
protection of EMS and hospital staff.

Removing contaminated clothing can eliminate a large proportion of external contamination.

3. Atropine

Atropine is the cornerstone antidote for muscarinic toxicity.

The clinical endpoint is not pupil normalization.

The endpoint is:

drying of secretions and improved ventilation.

Atropine may need to be repeated aggressively in severe poisoning.

4. Oximes

Oximes aim to reactivate acetylcholinesterase before aging occurs.

Commonly discussed agents include:

pralidoxime,
obidoxime,
HI-6.

Their effectiveness depends on:

agent type,
time since exposure,
degree of aging,
dose,
tissue penetration.

5. Benzodiazepines

Benzodiazepines are critical for:

seizure control,
prevention of status epilepticus,
reduction of secondary neuronal injury.

Examples include:

diazepam,
midazolam,
lorazepam.

6. Ventilatory support

Severe cases may require:

oxygen,
suction,
airway control,
intubation,
mechanical ventilation,
intensive care.

Respiratory support often determines survival.

TACTICAL AND EMS IMPLICATIONS

Nerve-agent incidents are not normal trauma calls.

They require:

CBRN discipline,
zoning,
PPE,
decontamination,
antidote logistics,
mass-casualty planning,
hospital notification.

HOT, WARM AND COLD ZONES

Hot zone

The contaminated area.

Only properly protected personnel should enter.

Warm zone

The decontamination corridor.

Patients move through controlled decontamination before definitive care.

Cold zone

The clean medical treatment area.

Advanced care should occur here whenever possible.

SECONDARY CONTAMINATION

A contaminated patient may contaminate:

rescuers,
ambulances,
emergency departments,
clothing,
medical equipment,
ventilation spaces.

This is one of the defining operational hazards of nerve-agent response.

AUTOINJECTORS

Military and emergency systems may use autoinjectors containing combinations of:

atropine,
pralidoxime,
diazepam or other anticonvulsants.

Examples include:

Mark I,
DuoDote,
ATNAA.

Their purpose is rapid field administration under contaminated or combat conditions.

FORENSIC CHEMISTRY

Modern investigation relies on:

environmental sampling,
biomedical sampling,
chain of custody,
OPCW-designated laboratories,
mass spectrometry,
protein adduct analysis,
international chemical weapons verification protocols.

SALISBURY 2018

The Salisbury incident involving Sergei Skripal and Yulia Skripal demonstrated several critical realities:

Novichok agents are operationally real,
secondary contamination is possible,
environmental persistence can create delayed casualties,
civilian emergency systems require CBRN readiness,
chemical attribution has major geopolitical consequences.

The later death of Dawn Sturgess after accidental exposure showed that contaminated objects may remain dangerous beyond the initial attack window.

NAVALNY 2020

The poisoning of Alexei Navalny further reinforced the geopolitical relevance of Novichok agents.

Key lessons included:

covert chemical operations may target individuals,
diagnosis may require specialised laboratories,
international verification is politically sensitive,
medical survival may depend on rapid supportive care.

NOVICHOK AND HYBRID WARFARE

Novichok agents are not merely toxicological weapons.

They can function as tools of:

intimidation,
assassination,
strategic signalling,
plausible deniability,
psychological warfare,
geopolitical coercion.

Their use creates effects beyond the poisoned individual:

public fear,
diplomatic crisis,
emergency-system disruption,
intelligence escalation,
international sanctions.

MYTHS VS SCIENTIFIC REALITY

Myth: “Anyone can make Novichok.”

Reality: These agents require advanced organophosphorus chemistry, hazardous precursors, specialised knowledge and extreme risk tolerance.

Myth: “They always kill instantly.”

Reality: Clinical progression depends on dose, route, agent, formulation, decontamination and speed of treatment.

Myth: “They are impossible to detect.”

Reality: Modern analytical toxicology can identify exposure through advanced laboratory methods.

Myth: “They are gases.”

Reality: Many nerve agents are liquids or aerosolisable compounds; persistence depends on the exact agent and formulation.

Myth: “Atropine cures everything.”

Reality: Atropine treats muscarinic toxicity but does not reverse nicotinic paralysis or established CNS injury.

LONG-TERM SEQUELAE

Survivors may experience:

neuropathy,
cognitive impairment,
mood disorders,
anxiety,
post-traumatic stress disorder,
fatigue,
sleep disturbance,
motor dysfunction,
possible seizure vulnerability.

The final outcome depends on:

hypoxic burden,
seizure duration,
time to antidotes,
ICU quality,
decontamination timing.

FINAL MEDICAL CONCLUSION

Novichok agents represent the convergence of:

advanced organophosphorus chemistry,
molecular neurotoxicology,
military doctrine,
clandestine intelligence operations,
CBRN emergency medicine,
geopolitical warfare.

From a medical perspective, survival depends on:

early recognition + immediate decontamination + aggressive atropinisation + timely oxime therapy + seizure control + advanced ventilatory support

Novichok agents are not fiction, not mythology and not simple “poisons”.

They are real fourth-generation nerve agents with profound implications for:

toxicology,
emergency medicine,
tactical medicine,
military medicine,
forensic science,
public health,
international security.

SELECTED SCIENTIFIC REFERENCES AND DOI

Chemical warfare agent NOVICHOK — review. DOI: 10.1016/j.fct.2018.09.015
Novichok nerve agents and toxicology review. DOI: 10.1007/s00204-023-03571-8
Frontiers in Toxicology review. DOI: 10.3389/ftox.2022.1004705
Detection of Novichok biomarkers and protein adducts. DOI: 10.1021/acs.chemrestox.1c00198
Clinical toxicology and nerve-agent management. DOI: 10.3390/jcm12062221
Chemical weapons and public health response. DOI: 10.1016/S1473-3099(18)30244-7
Nerve-agent poisoning clinical review. DOI: 10.1001/jama.2018.7044

OFFICIAL AND SCIENTIFIC SOURCES

OPCW: https://www.opcw.org
Frontiers in Toxicology: https://www.frontiersin.org
ACS Chemical Research in Toxicology: https://pubs.acs.org
PubMed Central: https://pmc.ncbi.nlm.nih.gov
ScienceDirect: https://www.sciencedirect.com

VISITAS RECIENTES

AUTISMO TEA PDF

We Support The Free Share of the Medical Information

Enlaces PDF por Temas

Nota Importante

Niveles de Alerta Antiterrorista en España. Nivel Actual 4 de 5.